MOLN 5.08 (-2.68%)
US60853G1067BiotechnologyBiotechnology

Molecular Partners (MOLN) Stock Highlights

5.08 | -2.68%
2024-12-21 06:12:47
Molecular Partners AG is a clinical stage biopharmaceutical company. The company focuses on the discovery, development and prospective commercialization of a new class of biopharmaceutical products. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The companys product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

Statistics

Range Today
5.06 5.19
Volume Today 15K
Range 1 Year
3.32 12.7
Volume 1 Year 5.11M
Range 3 Year
3.32 32.04
Volume 3 Year 11.78M
Range 10 Year
3.32 32.04
Volume 10 Year 19.11M

Highlights

Market Capitalization 232.95M (small)
Floating Shares 6.46M
Current Price 5.08
Price To Earnings -2.83
Price To Revenue 10.82
Price To Book 1.48
Earnings Per Share -2.16
Payout Ratio 0%

Performance

Latest -2.68%
1 Month -6.27%
3 Months +8.78%
6 Months -49.6%
1 Year +17.59%
3 Years -72.94%
5 Years -74.6%
10 Years -74.6%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.